Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84442332 | 8444233 | 2 | F | 20160708 | 20120307 | 20160712 | EXP | BR-AMGEN-BRASP2012012814 | AMGEN | 60.00 | YR | A | F | Y | 0.00000 | 20160711 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84442332 | 8444233 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, WEEKLY (25 MG APPLIED IN TWO INJECTIONS) | 103795 | 50 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | /wk | ||||||
| 84442332 | 8444233 | 2 | C | PREDNISOLONE. | PREDNISOLONE | 1 | UNK | 0 | |||||||||||
| 84442332 | 8444233 | 3 | C | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | UNK | 0 | |||||||||||
| 84442332 | 8444233 | 4 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 84442332 | 8444233 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 84442332 | 8444233 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 84442332 | 8444233 | Drug ineffective | |
| 84442332 | 8444233 | Joint injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |